# FDA Inspection 1028052 - Hubei Enoray Biopharmaceutical Co., Ltd. - July 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/hubei-enoray-biopharmaceutical-co-ltd/869aee6c-2df1-460a-b999-acc1924e7ff2
Source feed: FDA_Inspections

> FDA Inspection 1028052 for Hubei Enoray Biopharmaceutical Co., Ltd. on July 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028052
- Company Name: Hubei Enoray Biopharmaceutical Co., Ltd.
- Inspection Date: 2017-07-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266744 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/hubei-enoray-biopharmaceutical-co-ltd/fea90f0c-7e37-4e60-a49e-3ba87a256a82)
- [FDA Inspection 1266744 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/hubei-enoray-biopharmaceutical-co-ltd/1b70a711-26fa-4ee0-878c-46481721f9a0)

Company: https://www.keypedia.com/companies/hubei-enoray-biopharmaceutical-co-ltd/cc6f2be6-a1a6-4abf-832b-620aebc474a3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c